Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Hasegawa Y, Okamoto I, Takezawa K, Miyazaki M, Tsurutani J, Yonesaka K, Morinaga R, Tsuya A, Terashima M, Kudoh T, Azuma K, Kurata T, Nishikawa T, Fukuoka M, Nishimura Y, Nakagawa K. Hasegawa Y, et al. Among authors: tsurutani j. Invest New Drugs. 2013 Jun;31(3):599-604. doi: 10.1007/s10637-012-9833-7. Epub 2012 May 24. Invest New Drugs. 2013. PMID: 22623066 Clinical Trial.
Mutational analysis of the beta-tubulin gene in lung cancer.
Tsurutani J, Komiya T, Uejima H, Tada H, Syunichi N, Oka M, Kohno S, Fukuoka M, Nakagawa K. Tsurutani J, et al. Lung Cancer. 2002 Jan;35(1):11-6. doi: 10.1016/s0169-5002(01)00291-4. Lung Cancer. 2002. PMID: 11750707
Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer.
Oka M, Fukuda M, Kuba M, Ichiki M, Rikimaru T, Soda H, Tsurutani J, Nakamura Y, Kawabata S, Nakatomi K, Narasaki F, Nagashima S, Takatani H, Fukuda M, Kinoshita A, Kohno S. Oka M, et al. Among authors: tsurutani j. Eur J Cancer. 2002 Oct;38(15):1998-2004. doi: 10.1016/s0959-8049(02)00191-0. Eur J Cancer. 2002. PMID: 12376204 Clinical Trial.
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.
Fukuda M, Oka M, Soda H, Kinoshita A, Fukuda M, Nagashima S, Kuba M, Takatani H, Tsurutani J, Nakamura Y, Kasai T, Inoue Y, Soejima Y, Kohno S; Nagasaki Thoracic Oncology Group. Fukuda M, et al. Among authors: tsurutani j. Cancer Chemother Pharmacol. 2004 Dec;54(6):573-7. doi: 10.1007/s00280-004-0805-2. Epub 2004 Sep 10. Cancer Chemother Pharmacol. 2004. PMID: 15365766 Clinical Trial.
169 results